This inventor holds 2 USPTO granted patents. Top assignee: Nidek Co., Ltd.. Active years: 2006-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006-2010
Title: The Innovations of Takeshi Morimoto
Introduction
Takeshi Morimoto is a notable inventor based in Toyonaka, Japan. He has made significant contributions to the field of ophthalmic treatments, holding a total of 2 patents. His work focuses on innovative methods and apparatuses aimed at improving eye health and preventing retinal cell death.
Latest Patents
Morimoto's latest patents include an "Ophthalmic treatment stimulation method for inhibiting death of retinal cells." This method involves a two-step process where electrical stimulation is applied to retinal cells using electrodes placed outside the eye. The first step includes positioning a positive and negative electrode to provide stimulation, while the second step generates an electrical stimulation pulse with a current set between 20 µA and 300 µA. Another significant patent is the "Ophthalmic treatment apparatus," which features an electrode designed to apply electrical stimulation to retinal cells, connected to a pulse generator that produces the same range of electrical stimulation.
Career Highlights
Takeshi Morimoto is currently employed at Nidek Co., Ltd., a company known for its advancements in ophthalmic technology. His work at Nidek has allowed him to focus on developing innovative solutions for eye care, contributing to the company's reputation as a leader in the field.
Collaborations
Morimoto has collaborated with esteemed colleagues such as Tomomitsu Miyoshi and Takashi Fujikado. These partnerships have fostered a collaborative environment that enhances the development of cutting-edge ophthalmic technologies.
Conclusion
Takeshi Morimoto's contributions to ophthalmic treatment innovations reflect his dedication to improving eye health through technology. His patents demonstrate a commitment to advancing medical science and enhancing patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile